METHOD AND SYSTEM FOR BALLOON COUNTERPULSATION DURING AORTIC VALVE REPLACEMENT

• US 20160174992A1
• Filed: 03/02/2016
• Published: 06/23/2016
• Est. Priority Date: 09/21/2010
• Status: Active Grant

• Current Assignee: Hocor Cardiovascular Technologies, LLC
• Original Assignee: Hocor Cardiovascular Technologies, LLC
• Inventors: Ho, Paul C.
• Granted Patent: US 10,098,644 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 17/1204 temporary occlusion
• CPC Class Codes: A61B 17/12118 for positioning in conjunction with a stent
• CPC Class Codes: A61B 17/12136 Balloons
• CPC Class Codes: A61B 2017/00703 correcting for movement of heart, e.g. ECG-triggered
• CPC Class Codes: A61F 2/2427 Devices for manipulating or deploying heart valves during implantation
• CPC Class Codes: A61F 2250/0059 temporary
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters

Abstract

Methods and systems for regulating aortic regurgitation during aortic valve replacement or repair procedures utilize a temporary aortic valve (TAV) catheter and a controller. The temporary aortic valve catheter has an expandable occlusion device which can partially occlude the aortic lumen during ventricular diastole with a lesser occlusion during ventricular systole. Exemplary balloon structures include multiple, independently inflatable balloons which are inflated in synchrony with the cardiac cycle by the controller. By controlling aortic regurgitation, the repair or replacement protocols can be conducted with less interference from blood flow.

Claims

1. A device for regulating aortic regurgitation, said device comprising:

a tubular catheter body advancable through an ascending aorta of a subject;

a first occlusion element disposed at a distal end of the catheter body; and

a second occlusion element disposed at the distal end of the catheter body in parallel with the first occlusion element,

wherein the first and second occlusion elements are sized to at least partially occlude the ascending aorta when positioned therein,

wherein the first and second occlusion elements are independently expandable and contractable, and

wherein the first occlusion element is configured to expand and contract in synchrony with diastole and systole of a cardiac cycle, respectively, while the second occlusion element is configured remain expanded through the cardiac cycle.

2. The device of claim 1, wherein the tubular catheter body has a central lumen through which a replacement valve or other interventional tool can be advanced through.

3. The device of claim 1, wherein the first and second occlusion elements are disposed symmetrically about the distal end of the catheter body.

4. The device of claim 1, wherein the first occlusion element comprises a first inflatable element and the second occlusion element comprises a second inflatable element.

5. The device of claim 4, wherein the first inflatable element comprises a first inflatable balloon and the second inflatable element comprises a second inflatable balloon.

6. The device of claim 4, wherein the first and second inflatable elements are coupled to an inflation controller through at least one inflation tube.

7. The device of claim 6, wherein the inflation controller comprises a plurality of inflation connectors such that internal valving within the inflation controller allows for selective inflation of the first and second inflatable elements.

8. The device of claim 6, wherein the inflation controller is coupled to a cardiac cycle sensor and the inflation controller selectively inflates and deflates the first and second inflation elements in response to the cardiac cycle sensor.

9. The device of claim 8, wherein the cardiac cycle sensor comprises a heart rhythm monitor.

10. The device of claim 8, wherein the cardiac cycle sensor comprises a pressure sensor.

11. The device of claim 10, wherein the pressure sensor is disposed near a distal end of the tubular catheter body.

12. The device of claim 1, wherein the first occlusion element comprises a first plurality of expandable elements and the second occlusion element comprises a second plurality of expandable elements.

13. The device of claim 12, wherein the expandable elements of the first plurality of expandable elements alternate with the expandable elements of the second plurality of expandable elements about the distal end of the catheter body.

14. The device of claim 1, wherein the first and second occlusion elements occlude no more than 65% of the ascending aorta when both contracted.

15. The device of claim 1, wherein the first and second occlusion elements occlude no more than 50% of the ascending aorta when both contracted.

16. The device of claim 1, wherein the first and second occlusion elements occlude no more than 25% of the ascending aorta when both contracted.

17. The device of claim 1, wherein the first and second occlusion elements occlude from 40% of 90% of the ascending aorta when both fully expanded.

18. The device of claim 1, wherein, when the first and second occlusion elements are positioned in the ascending aorta, the first and second occlusion elements are both expanded during diastole to inhibit aortic regurgitation while allowing perfusion of the coronary arteries via the sinus of valsalva.

19. The device of claim 1, wherein, when the first and second occlusion are positioned in the ascending aorta, the first occlusion element is contracted while the second occlusion element is expanded during systole to lessen inhibition of blood flow from the left ventricle to the aorta.

20. The device of claim 1, wherein the first occlusion element is configured to expand and contract with diastole and systole, respectively every 1 of n cardiac cycles, where n is an integer from 1 to 10.